(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.08%47.08B | 15.87%35.51B | 13.03%24.08B | 4.13%10.43B | -37.99%41.63B | -43.69%30.65B | -49.82%21.3B | -47.44%10.01B | 3.11%67.13B | 20.30%54.43B |
Operating income | 13.08%47.08B | 15.87%35.51B | 13.03%24.08B | 4.13%10.43B | -37.99%41.63B | -43.69%30.65B | -49.82%21.3B | -47.44%10.01B | 3.11%67.13B | 20.30%54.43B |
Cost of sales | -4.81%-34.11B | ---- | -2.88%-17.36B | ---- | 36.54%-32.54B | ---- | 47.00%-16.87B | ---- | -10.30%-51.28B | ---- |
Operating expenses | -4.81%-34.11B | -5.93%-25.66B | -2.88%-17.36B | 4.11%-7.67B | 36.54%-32.54B | 41.17%-24.22B | 47.00%-16.87B | 42.32%-8B | -10.30%-51.28B | -27.29%-41.17B |
Gross profit | 42.67%12.97B | 53.36%9.86B | 51.74%6.72B | 36.94%2.75B | -42.67%9.09B | -51.51%6.43B | -58.30%4.43B | -61.17%2.01B | -14.86%15.85B | 2.76%13.26B |
Selling expenses | -34.99%-3.56B | -36.43%-2.57B | -46.63%-1.7B | -35.78%-676.84M | 24.13%-2.64B | 32.99%-1.88B | 43.86%-1.16B | 52.67%-498.47M | 14.16%-3.47B | 10.45%-2.81B |
Administrative expenses | 5.25%-2.27B | -14.26%-1.27B | -26.86%-1.04B | -11.67%-375.18M | -21.03%-2.4B | 10.14%-1.11B | 21.85%-819M | 23.89%-335.98M | 16.19%-1.98B | 3.67%-1.23B |
Research and development expenses | -37.26%-3.44B | -43.42%-2.57B | -41.27%-1.59B | -48.70%-645.46M | 35.14%-2.51B | 39.06%-1.79B | 44.04%-1.12B | 46.55%-434.07M | -15.55%-3.87B | -71.72%-2.94B |
Profit from asset sales | ---- | -531.59%-19.29M | ---- | -229.82%-4.29M | ---- | -93.66%4.47M | ---- | -93.71%3.3M | ---- | -62.02%70.51M |
Revaluation surplus | ---- | -169.74%-126.9M | ---- | -92.65%4.35M | ---- | 15.83%181.96M | ---- | -46.54%59.21M | ---- | 30.53%157.1M |
-Changes in the fair value of other assets | ---- | -169.74%-126.9M | ---- | -92.65%4.35M | ---- | 15.83%181.96M | ---- | -46.54%59.21M | ---- | 30.53%157.1M |
Impairment and provision | -78.03%-794M | -30.63%-396.28M | -16.44%-255M | -2.42%-107.12M | 40.21%-446M | 40.90%-303.36M | 49.42%-219M | 41.48%-104.58M | 55.65%-746M | 42.94%-513.29M |
-Other impairment is provision | -78.03%-794M | -30.63%-396.28M | -16.44%-255M | -2.42%-107.12M | 40.21%-446M | 40.90%-303.36M | 49.42%-219M | 41.48%-104.58M | 55.65%-746M | 42.94%-513.29M |
Special items of operating profit | -4.79%935M | -23.20%519.39M | -79.05%145M | -48.13%196.44M | -30.50%982M | -27.26%676.31M | 7.45%692M | 151.49%378.71M | -3.35%1.41B | 37.70%929.77M |
Operating profit | 84.20%3.84B | 59.09%3.18B | 26.91%2.29B | 3.55%1.06B | -71.07%2.08B | -69.79%2B | -68.46%1.8B | -65.03%1.02B | -16.70%7.2B | 0.86%6.62B |
Financing income | -5.33%284M | ---- | -45.33%123M | ---- | 4,900.00%300M | ---- | 389.13%225M | ---- | 103.90%6M | ---- |
Financing cost | ---- | -73.51%144.97M | ---- | -2,247.08%-123.92M | ---- | 1,043.85%547.36M | ---- | 109.39%5.77M | ---- | 235.14%47.85M |
Share of profits of associates | 17.69%153M | ---- | 10.29%75M | ---- | -15.58%130M | ---- | -29.90%68M | ---- | -15.38%154M | ---- |
Special items of earning before tax | ---- | -15.72%48.79M | ---- | -23.70%11.7M | ---- | -29.54%57.89M | ---- | 10.32%15.33M | ---- | 54.30%82.16M |
Earning before tax | 70.06%4.27B | 29.57%3.38B | 18.62%2.49B | -9.32%944.45M | -65.86%2.51B | -61.41%2.61B | -64.22%2.1B | -63.71%1.04B | -15.12%7.36B | 2.56%6.75B |
Tax | -431.40%-457M | 19.65%-312.7M | 21.20%-249M | 18.76%-85.7M | 90.83%-86M | 58.44%-389.17M | 65.31%-316M | 76.32%-105.48M | 27.68%-938M | -10.67%-936.46M |
After-tax profit from continuing operations | 57.25%3.82B | 38.21%3.06B | 25.69%2.24B | -8.26%858.75M | -62.21%2.43B | -61.88%2.22B | -64.02%1.78B | -61.40%936.05M | -12.92%6.42B | 1.37%5.81B |
Earning after tax | 57.25%3.82B | 38.21%3.06B | 25.69%2.24B | -8.26%858.75M | -62.21%2.43B | -61.88%2.22B | -64.02%1.78B | -61.40%936.05M | -12.92%6.42B | 1.37%5.81B |
Minority profit | 235.44%265M | 338.71%207.6M | 318.60%180M | 63.99%48.69M | -31.90%79M | -25.07%47.32M | -37.68%43M | 223.22%29.69M | 54.67%116M | 28.67%63.15M |
Profit attributable to shareholders | 51.26%3.55B | 31.65%2.86B | 18.43%2.06B | -10.63%810.06M | -62.76%2.35B | -62.29%2.17B | -64.40%1.74B | -62.48%906.37M | -13.61%6.3B | 1.13%5.75B |
Basic earnings per share | 54.86%0.4305 | 36.00%0.34 | 21.95%0.2495 | -9.09%0.1 | -63.31%0.278 | -64.29%0.25 | -65.71%0.2046 | -63.33%0.11 | -22.48%0.7578 | -7.89%0.7 |
Diluted earnings per share | 54.80%0.4285 | 36.00%0.34 | 21.89%0.2472 | -9.09%0.1 | -63.24%0.2768 | -64.29%0.25 | -65.56%0.2028 | -63.33%0.11 | -22.16%0.7529 | -7.89%0.7 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianzhi International Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data